跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAYBUE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DAYBUE
Authorized
STANDARD
DAYBUE
ACADIA Pharmaceuticals, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5463a678b6c02e53
Company
ACADIA Pharmaceuticals, Inc.
Type
Standard
Approval Details
Approval Id
5463a678b6c02e53
Drug Approval Canada Name
DAYBUE
Product Name
DAYBUE
Status
Marketed
Status Date
2025-02-12
Original Market Date
2025-02-12
Din
02552523
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Gastric , Oral
Schedule
Prescription
Ahfs
28:92.00
Atc Original
N07XX24 TROFINETIDE
Atc Name
n 07 xx 24
Aig Number
0166284001
Company Name
ACADIA Pharmaceuticals, Inc.
Company Address
12830 El Camino Real, Suite 400, San Diego, California, United States, 92130
Company Detail Path
/organization/acadia-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
ACADIA Pharmaceuticals, Inc.
Country Name
United States
Province Name
California
City Name
加利福尼亚州圣迭戈县
Website
http://www.acadia.com
Active Ingredients
TROFINETIDE
200 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5463a678b6c02e53
Type
Standard
Back to Health Canada Approvals